iBreastExam 1.3.40

iBreastExam is a hand-held, battery-powered wireless medical technology that allows for affordable and radiation-free breast examination and documentation at the point of care. This device has been clinically validated across multiple independent studies with 7,500 women enrolled. Furthermore, iBreastExam has received market clearance from several regulators globally, including the US FDA, CE Mark, and others. To date, over 500,000 women in 10 countries have benefitted from iBreastExam, leading to the identification of hundreds of early cancer cases. Noteworthy accolades include the World Bank’s 2022 Global Women’s Healthtech Award, Innovative Health Technology recognition from the World Health Organization (WHO), and Thought Leader recognition at the 2021 Annual Meeting of the American College of Obstetricians and Gynecologists (by ACOG TV).

The creators of iBreastExam, UE LifeSciences, are a women’s health company with a focus on preventive oncology. They specialize in designing, developing, and commercializing medical technology solutions that facilitate the early detection of prevalent cancers in women.

Disclaimer: It is recommended to consult a healthcare professional for medical advice in addition to utilizing this technology before making any healthcare decisions.